HARSHAL JANI: Open Payments
NPI 1154361566 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 15 payments from 9 companies in 2025. Trend: 2023 $502 · 2024 $399 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $63 |
| Lilly USA, LLC | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Exact Sciences Corporation | 2 | $29 |
| SANOFI PASTEUR INC. | 1 | $24 |
| ABBVIE INC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Corcept Therapeutics | 1 | $18 |
Products named: Wegovy, MOUNJARO, BREZTRI, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, QULIPTA, XIFAXAN, SPRAVATO, Korlym.
Industry payments across FL — which companies pay providers there.
